Dirk De Bacquer
Overview
Explore the profile of Dirk De Bacquer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
308
Citations
8319
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ferrannini G, Tuomilehto J, De Backer G, Kotseva K, Mellbin L, Schnell O, et al.
Lancet Diabetes Endocrinol
. 2024 Sep;
12(11):790-798.
PMID: 39326426
Background: Glucose perturbations can be detected by fasting plasma glucose (FPG), HbA, and the oral glucose tolerance test (OGTT). The highest yield is provided by OGTT. HbA is considered more...
2.
Cillekens B, Coenen P, Huysmans M, Holtermann A, Troiano R, Mork P, et al.
J Sport Health Sci
. 2024 Sep;
14:100987.
PMID: 39277081
Background: There is insufficient evidence to provide recommendations for leisure-time physical activity among workers across various occupational physical activity levels. This study aimed to assess the association of leisure-time physical...
3.
Coenen P, Huysmans M, Holtermann A, Troiano R, Mork P, Krokstad S, et al.
Br J Sports Med
. 2024 Sep;
58(24):1527-1538.
PMID: 39255999
Objective: Health effects of different physical activity domains (ie, during leisure time, work and transport) are generally considered positive. Using data, we assessed independent associations of occupational and leisure-time physical...
4.
McEvoy J, Jennings C, Kotseva K, De Bacquer D, De Backer G, Erlund I, et al.
Eur Heart J
. 2024 Aug;
45(39):4184-4196.
PMID: 39212219
Background And Aims: INTERASPIRE is an international study of coronary heart disease (CHD) patients, designed to measure if guideline standards for secondary prevention and cardiac rehabilitation are being achieved in...
5.
Van Brusselen D, De Troeyer K, van Vliet M, Avonts D, Nemery B, Liesenborghs L, et al.
Eur J Pediatr
. 2024 Mar;
183(5):2431-2442.
PMID: 38470521
This case-control study aimed to investigate the association between short-term (1 to 5 days) and medium-term (31 days) exposure to air pollutants (PM, PM, BC, NO) at home/daycare and the...
6.
Amrouch C, Vauterin D, Amrouch S, Grymonprez M, Dai L, Damiano C, et al.
Drugs Aging
. 2023 Nov;
41(1):13-30.
PMID: 37976015
Aim: Polypharmacy in multimorbid older patients with atrial fibrillation (AF) is a risk factor for potentially inappropriate prescribing (PIP). We aimed to systematically assess the evidence on the prevalence of...
7.
Survival of cervical cancer patients at Moi teaching and Referral Hospital, Eldoret in western Kenya
Mwaliko E, Itsura P, Keter A, De Bacquer D, Buziba N, Bastiaens H, et al.
BMC Cancer
. 2023 Nov;
23(1):1104.
PMID: 37957644
Background: Cervical cancer is a major health burden and the second most common cancer after breast cancer among women in Kenya. Worldwide cervical cancer constitutes 3.1% of all cancer cases....
8.
Hulin S, Bolliger L, Lukan J, Caluwaerts A, De Neve R, Lustrek M, et al.
Stress Health
. 2023 Sep;
40(3):e3315.
PMID: 37724331
Existing literature indicates that academic staff experience increasing levels of work stress. This study investigated associations between day-to-day threat and challenge appraisal and day-to-day problem-focused coping, emotion-focused coping, and seeking...
9.
Ketels M, Belligh T, De Bacquer D, Clays E
Scand J Work Environ Health
. 2023 Sep;
49(8):578-587.
PMID: 37713180
Objectives: This prospective study aimed to investigate the relation between occupational physical activity (OPA), leisure-time physical activity (LTPA) and sickness absence (SA). A second aim was to explore the possible...
10.
Burger P, Savarese G, Tromp J, Adamson C, Jhund P, Benson L, et al.
Eur J Heart Fail
. 2023 Sep;
25(11):1962-1975.
PMID: 37691140
Aims: Although trials have proven the group-level effectiveness of various therapies for heart failure with reduced ejection fraction (HFrEF), important differences in absolute effectiveness exist between individuals. We developed and...